Today’s clinical trial patients are digital and health savvy consumers. Check out what Jeff Lee, CEO, mProve Health, and top patient engagement experts from PwC, Rx-Edge, Sciformix, and PMRG/Health Literacy Initiative say about engagement strategies that work for patients in clinical trials. Read the full article here.
Are you attending the 4th Annual Mobile in Clinical Trials Conference on Sept 6 in Boston? Don’t miss the opening panel at 8:40am with the pharmaceutical industry’s top mobile experts: Munther Baara, Senior Director, Clinical Paradigm, Pfizer; Jacob LaPorte, Head of Digital Development, Novartis; Jane Myles, Head, Operational Intelligence and Innovation, Genentech/Roche; and Alex Simmonds Business Partner, Digital Clinical, R&D IT, Bristol-Myers Squibb, sharing how they’ve implemented apps, devices, and other mobile solutions on clinical trials. (more…)
Jeff Lee, CEO, mProve Health, was recently featured in the September/October issue of The Journal of mHealth, sharing his story of founding a company that develops innovative mobile patient technology for clinical trials.
The full article is on page 8. Please click here to read.
Jeff Lee, CEO, mProve Health, was recently featured in the May issue of Prostatepedia, a monthly periodical featuring conversations with leading medical experts in the prostate cancer world. He discusses how mobile technology affects oncology clinical trials and explains what mHealth applications can do for cancer patients in research studies.
Demonstrating Profitability for the Seventh Consecutive Year, mProve Health Moves Growing Team into New Headquarter Offices
WASHINGTON, DC – May 22, 2017, mProve Health, a leading provider of mobile technologies used by life science organizations to connect and engage patients with global clinical research studies, announces unprecedented 12-month growth and the addition of 25% more new pharmaceutical companies and CROs to its client base.